Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Levetiracetam add-on for drug-resistant focal epilepsy.
Mbizvo GK, Chandrasekar B, Nevitt SJ, Dixon P, Hutton JL, Marson AG. Mbizvo GK, et al. Among authors: hutton jl. Cochrane Database Syst Rev. 2020 Jun 30;6(6):CD001901. doi: 10.1002/14651858.CD001901.pub3. Cochrane Database Syst Rev. 2020. PMID: 35658745 Free PMC article. Review.
Tiagabine add-on for drug-resistant partial epilepsy.
Pulman J, Marson AG, Hutton JL. Pulman J, et al. Among authors: hutton jl. Cochrane Database Syst Rev. 2012 May 16;5(5):CD001908. doi: 10.1002/14651858.CD001908.pub2. Cochrane Database Syst Rev. 2012. PMID: 22592677 Free PMC article. Updated. Review.
Tiagabine add-on for drug-resistant partial epilepsy.
Pulman J, Hutton JL, Marson AG. Pulman J, et al. Among authors: hutton jl. Cochrane Database Syst Rev. 2014 Feb 5;2014(2):CD001908. doi: 10.1002/14651858.CD001908.pub3. Cochrane Database Syst Rev. 2014. PMID: 24500879 Free PMC article. Review.
Topiramate add-on for drug-resistant partial epilepsy.
Pulman J, Jette N, Dykeman J, Hemming K, Hutton JL, Marson AG. Pulman J, et al. Among authors: hutton jl. Cochrane Database Syst Rev. 2014 Feb 25;(2):CD001417. doi: 10.1002/14651858.CD001417.pub3. Cochrane Database Syst Rev. 2014. PMID: 24570033 Review.
Gabapentin add-on treatment for drug-resistant focal epilepsy.
Panebianco M, Al-Bachari S, Weston J, Hutton JL, Marson AG. Panebianco M, et al. Among authors: hutton jl. Cochrane Database Syst Rev. 2018 Oct 24;10(10):CD001415. doi: 10.1002/14651858.CD001415.pub3. Cochrane Database Syst Rev. 2018. PMID: 30357813 Free PMC article. Updated.
Tiagabine add-on therapy for drug-resistant focal epilepsy.
Bresnahan R, Martin-McGill KJ, Hutton JL, Marson AG. Bresnahan R, et al. Among authors: hutton jl. Cochrane Database Syst Rev. 2019 Oct 14;10(10):CD001908. doi: 10.1002/14651858.CD001908.pub4. Cochrane Database Syst Rev. 2019. PMID: 31608990 Free PMC article. Review.
Topiramate add-on therapy for drug-resistant focal epilepsy.
Bresnahan R, Hounsome J, Jette N, Hutton JL, Marson AG. Bresnahan R, et al. Among authors: hutton jl. Cochrane Database Syst Rev. 2019 Oct 23;10(10):CD001417. doi: 10.1002/14651858.CD001417.pub4. Cochrane Database Syst Rev. 2019. PMID: 31642054 Free PMC article. Review.
Gabapentin add-on treatment for drug-resistant focal epilepsy.
Panebianco M, Al-Bachari S, Hutton JL, Marson AG. Panebianco M, et al. Among authors: hutton jl. Cochrane Database Syst Rev. 2021 Jan 12;1(1):CD001415. doi: 10.1002/14651858.CD001415.pub4. Cochrane Database Syst Rev. 2021. PMID: 33434292 Free PMC article.
127 results